FiercePharmaAsia—AstraZeneca’s China slowdown; Novartis’ Asia CAR-T site; Clover’s COVID-19 funding

FiercePharmaAsia—AstraZeneca’s China slowdown; Novartis’ Asia CAR-T site; Clover’s COVID-19 funding
aliu
Fri, 11/06/2020 – 07:45